Refractive And Visual Outcomes Of A Lens With Wave Front Technology In Patients With Associated Surgical Retinal Pathology

To analyze the refractive and visual outcomes of AcrySof Vivity lens in patients with an associated surgical retinal pathology. To evaluate the predictability of the procedure. To define the efficacy and safety indexes.

Retrospective study in one single clinical site 

Retrospective study of patients who underwent retinal surgery at our clinic (macular hole (MH), vitreomacular traction (VMT), epiretinal membrane (ERM), retinal detachment (RD)) and also implant of Vivity lens. Six months later monocular uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) were evaluted (decimal scale) and so uncorrected intermediate visual acuity (UIVA) and uncorrected near visual acuity (UNVA). Efficacy and safety indexes were obtained. 

38 eyes of 38 patients were analyzed. 12 men and 21 women. The mean age was 65.22±9.01 years old(range 31-81). Associated retinal pathology: 23 ERM, 5 MH, 2VMT and 7 RD. 27 surgeries were phacovitrectomy; 11 cases were sequential surgeries [7patients underwent retinal surgery at first, and only in 4 cases the implant of the lens was the first surgery  developped (2 RD, 2 MH)]. 9 lenses were toric and 29 were spherical. The mean spherical lens power was 19.56±3.15 dyopters(D). Outcomes at 6 months: Monocular UDVA and CDVA were 0.72±0.19 and 0.80±0.18 respectively. UIVA was 0.70±0.25. UNVA  was 0.45±0.19. The mean postoperative sphere was -0.23±0.38 D. Efficacy and safety indexes were 0.97 and 1.08 respectively. 

The implant of Vivity lens in patients with associated surgical retinal pathology is an effective, safety and predictable procedure. Efficacy and safety indexes are within an aceptable range. Good levels of intermediate and near visual acuity were obtained in this group of patients.